Sei Investments Co. Sells 4,115 Shares of Chemed Co. (NYSE:CHE)

Sei Investments Co. lessened its holdings in shares of Chemed Co. (NYSE:CHE - Free Report) by 10.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 34,753 shares of the company's stock after selling 4,115 shares during the quarter. Sei Investments Co. owned 0.23% of Chemed worth $18,414,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CHE. Raymond James Financial Inc. bought a new position in Chemed in the fourth quarter valued at approximately $42,023,000. FMR LLC raised its holdings in shares of Chemed by 23.8% during the third quarter. FMR LLC now owns 238,616 shares of the company's stock worth $143,401,000 after acquiring an additional 45,917 shares during the period. Principal Financial Group Inc. lifted its position in Chemed by 114.1% in the 4th quarter. Principal Financial Group Inc. now owns 74,658 shares of the company's stock valued at $39,554,000 after acquiring an additional 39,791 shares in the last quarter. Aureus Asset Management LLC boosted its stake in Chemed by 3,147.2% in the 3rd quarter. Aureus Asset Management LLC now owns 29,939 shares of the company's stock worth $17,993,000 after purchasing an additional 29,017 shares during the period. Finally, Boston Trust Walden Corp increased its holdings in Chemed by 10.0% during the 4th quarter. Boston Trust Walden Corp now owns 242,172 shares of the company's stock worth $128,303,000 after purchasing an additional 22,105 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Royal Bank of Canada upped their price objective on Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research report on Friday, March 14th. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th.

Remove Ads

Chemed Price Performance

NYSE:CHE traded up $2.82 on Tuesday, hitting $618.14. 260,403 shares of the company's stock were exchanged, compared to its average volume of 94,493. The firm has a 50-day moving average price of $576.54 and a 200-day moving average price of $567.29. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $639.61. The company has a market cap of $9.05 billion, a P/E ratio of 31.23, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.32%. Chemed's payout ratio is presently 10.05%.

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now owns 102,679 shares in the company, valued at $60,957,441.93. This represents a 1.91 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Insiders own 3.32% of the company's stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.